Why does the prognosis remain so poor in human rabies?

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 6, 2010, Pages 623-625

  Jackson, Alan C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; KETAMINE; MIDAZOLAM; PHENOBARBITAL; RABIES VACCINE; RIBAVIRIN; VIRUS ANTIBODY;

CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL PROTOCOL; COMA; CONTINUOUS INFUSION; EDITORIAL; HUMAN; IMMUNE RESPONSE; INCIDENCE; NONHUMAN; PROGNOSIS; RABIES; RABIES VIRUS; TREATMENT FAILURE; VIRAL CLEARANCE;

CENTRAL NERVOUS SYSTEM VIRAL DISEASES; COMA; HUMANS; PROGNOSIS; RABIES; RABIES VIRUS;

EID: 77953240974     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.50     Document Type: Editorial

References (17)

1. World Health Organization. WHO expert consultation on rabies: first report. World Health Organization, Geneva, Switzerland, 1-88 (2005).
2. Lafon M. Immunology. In: Rabies. Jackson AC, Wunner WH (Eds). Elsevier Academic Press, London, UK, 489-504 (2007).
3. Roy A, Phares TW, Koprowski H, Hooper DC. Failure to open the blood- brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J. Virol. 81(3), 1110-1118 (2007).
4. Roy A, Hooper DC. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J. Virol. 81(15), 7993-7998 (2007).
5. Fabis MJ, Phares TW, Kean RB, Koprowski H, Hooper DC. Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity. Proc. Natl Acad. Sci. USA 105(40), 15511-15516 (2008).
6. Jackson AC, Warrell MJ, Rupprecht CE et al. Management of rabies in humans. Clin. Infect. Dis. 36(1), 60-63 (2003).
7. Lockhart BP, Tsiang H, Ceccaldi PE, Guillemer S. Ketamine-mediated inhibition of rabies virus infection in vitro and in rat brain. Antivir. Chem. Chemother. 2, 9-15 (1991).
8. Willoughby RE Jr, Tieves KS, Hoffman GM et al. Survival after treatment of rabies with induction of coma. N. Engl. J. Med. 352(24), 2508-2514 (2005).
9. Hu WT, Willoughby RE Jr, Dhonau H, Mack KJ. Long-term follow-up after treatment of rabies by induction of coma. N. Engl. J. Med. 357(9), 945-946 (2007).
10. Jackson AC. Recovery from rabies. N. Engl. J. Med. 352(24), 2549-2550 (2005).
11. Jackson AC. Update on rabies diagnosis and treatment. Curr. Infect. Dis. Rep. 11(4), 296-301 (2009).
12. Weli SC, Scott CA, Ward CA, Jackson AC. Rabies virus infection of primary neuronal cultures and adult mice: failure to demonstrate evidence of excitotoxicity. J. Virol. 80(20), 10270-10273 (2006).
13. synoptic overview. Stroke 40(Suppl. 3), S111-S114 (2009).
14. Lafon M. Bat rabies - the Achilles heel of a viral killer? Lancet 366(9489), 876-877 (2005).
15. Hattwick MAW, Weis TT, Stechschulte CJ, Baer GM, Gregg MB. Recovery from rabies: a case report. Ann. Intern. Med. 76, 931-942 (1972).
16. McDermid RC, Saxinger L, Lee B et al. Human rabies encephalitis following bat exposure: failure of therapeutic coma. Can. Med. Assoc. J. 178(5), 557-561 (2008).
17. Maier T, Schwarting A, Mauer D et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin. Infect. Dis. 50(8), 1112-1119 (2010).